Literature DB >> 25459563

Implications of multiple freeze-thawing on respiratory samples for culture-independent analyses.

Leah Cuthbertson1, Geraint B Rogers2, Alan W Walker3, Anna Oliver4, Lucas R Hoffman5, Mary P Carroll6, Julian Parkhill7, Kenneth D Bruce8, Christopher J van der Gast9.   

Abstract

BACKGROUND: Best practice when performing culture-independent microbiological analysis of sputum samples involves their rapid freezing and storage at -80°C. However, accessing biobanked collections can mean that material has been passed through repeated freeze-thaw cycles. The aim of this study was to determine the impact of these cycles on microbial community profiles.
METHODS: Sputum was collected from eight adults with cystic fibrosis, and each sample was subjected to six freeze-thaw cycles. Following each cycle, an aliquot was removed and treated with propidium monoazide (PMA) prior to DNA extraction and 16S rRNA gene pyrosequencing.
RESULTS: The impact of freeze-thaw cycles was greatest on rare members of the microbiota, with variation beyond that detected with within-sample repeat analysis observed after three cycles.
CONCLUSION: Four or more freeze thaw cycles result in a significant distortion of microbiota profiles from CF sputum.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  Biobank; Microbiome; Microbiota; Propidium monoazide; Pyrosequencing; Sputum

Mesh:

Year:  2014        PMID: 25459563      PMCID: PMC4793934          DOI: 10.1016/j.jcf.2014.10.004

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


1. Introduction

The application of next-generation sequencing technologies for the investigation of lower respiratory tract infections in patients with cystic fibrosis has revealed complex and highly diverse microbial communities [1,2]. As technologies have improved and the associated costs have fallen, it is becoming possible to use these platforms, not only for research but also for diagnostic microbiology [3], making it more important than ever to identify and minimise the introduction of bias. Spontaneously expectorated sputum is one of the most common specimen types used to investigate the microbial community responsible for lower respiratory infections in adults with CF. In order to perform culture-independent analysis on a representative airway sample, the methods used to collect and store specimens are hugely important. Current best practice involves the rapid stabilisation of sputum samples by freezing at −80 °C within 12 h of collection [4]. To allow profiling of the viable microbial community, samples can be treated with propidium monoazide (PMA) to remove the impact of extracellular DNA or DNA from dead and damaged cells, prior to DNA extraction and DNA sequencing [5]. Received wisdom suggests that once defrosted, respiratory samples may not be refrozen and sub-sampled again at a later date without incurring significant changes in the microbial community. There is an increasing awareness of the importance of in-depth analysis for the investigation of the microbial communities responsible for infection. This has lead to many clinics collecting large detailed sample biobanks in ultralow temperature freezers, which can be accessed in order to address a wide range of clinical questions. However, biobanked samples may be accessed multiple times for culture independent analysis, thus passing though several freeze thaw cycles, a process that could result in changes to the microbial community. To date, no studies have used next-generation sequencing technologies to define how multiple freeze–thaw cycles affect the microbial community within collected sputum. We hypothesized that microbial community profiles would be significantly altered with each additional freeze–thaw cycle when analysed using 16S rRNA gene pyrosequencing.

2. Methods

2.1. Sample collection

Sputum samples were collected, under full ethical approval from the Southampton and South West Hampshire Research Ethics Committee (06/Q1704/26), from eight patients attending the regional Cystic Fibrosis Centre in Southampton General Hospital. All patients were chronically colonised with Pseudomonas aeruginosa. Patients were selected based on their ability to typically produce more than 2 ml of sputum. Sputum samples were collected and frozen at −80 °C within 1 h. Each sputum sample was subjected to six freeze–thaw cycles. Samples were removed from the −80 °C freezer, a 250 μl aliquot removed for DNA extraction, and the remaining sample allowed to completely thaw at room temperature for 30 min before being returned to −80 °C for 24 h.

2.2. DNA extraction and pyrosequencing

Sputum samples were washed three times with 1× phosphate buffered saline to remove saliva, as previously described [1]. Extracellular DNA and DNA from non-viable cells were excluded from analysis via crosslinking with PMA [6,7] prior to DNA extraction, as described previously [8]. Bacterial Golay barcode-encoded FLX amplicon pyrosequencing was performed using the primer 338F (3′- ACTCCTACGGGAGGCAGCAG) and 926R (3′- CCGTCAATTCMTTTRAGT). Initial generation of 16S rRNA gene amplicons involved a one step PCR of 25 cycles using AccuPrime™ Taq DNA Polymerase High Fidelity (Invitrogen, Carlsbad, CA). 454 pyrosequencing using the Lib-L kit was performed at the Wellcome Trust Sanger Institute, Hinxton, UK. Resulting data were analysed using the Mothur sequencing analysis platform [9] as described previously [4]. The raw sequence data generated within the current study have been submitted to the NCBI Short Read Archive database under the study accession number SRP040968. The barcodes associated with each sample are shown in Table S1. Two aliquots were excluded due to insufficient number of sequence reads generated.

2.3. Statistical analysis

Statistical analysis was performed in R [10]. Changes in bacterial diversity were assessed using three complementary measures: species richness (S*, the total number of species), Shannon–Wiener (H′, a metric accounting for both number and relative abundance of species), and Simpson’s (1-D, a measure of the probability that two species randomly selected from a sample will differ) indices of diversity as described previously [4,11]. The Bray–Curtis (SBC, which accounts for the number and abundance of species present in each community and those that are shared), resulting in a value between 0 and 1 (higher values indicating greater similarity) measure of similarity was used to assess changes in community composition with each freeze–thaw cycle. To avoid potential bias, all measures were calculated using randomised resampling to a uniform number of sequence reads per sample [5]. Mean diversity measures were calculated from the re-sampling of the reads from each specimen to the lowest number of sequence reads among all specimens (n = 261) for 1000 iterations. SBC was calculated by re-sampling to the minimum number of sequence reads per specimen within each patient and comparing community composition to the original sample for 1000 iterations. Bacterial species detected at the first point for each patient were partitioned into common and rare species using rank abundance curves [12]. The R package nlme [13] was used to fit mixed effect models to investigate the relationships between measures of diversity, similarity, and number of freeze thaw cycles. r values were calculated using the MuMIn package [14].

3. Results

To test the study hypothesis, sputum samples from eight CF patients were subjected to six freeze–thaw cycles. Aliquots of sputum were removed for DNA extraction and 16S rRNA gene pyrosequencing to assess the bacterial community after each cycle, and the remaining sample was allowed to defrost completely before being returned to −80 °C. All samples were treated with PMA prior to DNA extraction to focus the analysis on the viable bacterial community. A total of 106,065 sequences (mean ± standard error (SE) per sample 2306 ± 239) were generated from 46 samples, identifying 49 genera and 76 distinct operational taxonomic units (OTUs) classified to species level (Table S2).

3.1. Bacterial diversity

Species richness, S*, was found to be highly variable between patients (max = 49, min = 4), no pattern in raw richness values was observed over the freeze–thaw cycles either within patients (P = 0.6, r = 0.0004) or when using randomised resampling to calculate mean S* (P = 0.7, r = 0.0001). High levels of variability in bacterial diversity were also observed between patients as measured by H′ and 1-D. However, as with S*, no pattern in either of these diversity measures was observed over the 6 freeze–thaw cycles H′ (P = 0.4, r = 0.001), 1-D (P = 0.1, r = 0.003) (Fig. 1).
Fig. 1

Boxplots from each patient showing variation in diversity over the 6 freeze–thaw cycles. Values of (A) species richness (S*), (B) Shannon–Wiener index of diversity (H′), and (C) Simpson’s index of diversity (1-D) were calculated with a uniform re-sample size following 1000 iterations in each instance. Lines in boxplot represent mean and standard deviation of the mean (n = 6); whiskers represent 25th and 75th percentiles.

3.2. Bacterial community membership

Changes in community composition were compared using the SBC measure of similarity. A significant decrease in similarity was observed over the 6 cycles (P < 0.0001, r = 0.40) (Fig. 2). Variation in intra-sample composition could contribute to the effect associated with freeze–thaw cycles [4,15]. Therefore, to account for within-sample variation, a cut off value for similarity was calculated by comparing the within-sample similarities of triplicate sequence datasets of eight samples that were published previously [4]. Based on this data, Bray–Curtis similarity values below 0.682 were judged to differ significantly from the original sample.
Fig. 2

Mean changes in bacterial community composition over six freeze–thaw cycles, using Bray–Curtis index of similarity for (A) whole communities, (B) common and (C) rare species groups. Error bars represent the standard error of the mean (n = 6). Whole community similarity was calculated with a uniform re-sample size following 1000 iterations. Solid lines represent the overall mean similarity for within sample replicates and dashed lines represent the standard error of the mean (n = 24).

To minimise bias, changes in similarity were measured using randomised resampling to a uniform subsample size. Analysis showed that, despite a significant trend of decreasing similarity between aliquots within each sample over the six freeze–thaw cycles, none of these changes in within-sample similarity fell below the cut-off value of 0.682 for significant within-sample variation. To investigate the drivers of this trend in community composition, we partitioned the community into common and rare species using rank abundance curves, indicating the breakpoint between the common and rare using the inflection point (Fig. S1) [12]. Once partitioned, the Bray–Curtis similarity was calculated for the common and rare species. The common and abundant species were most important in determining the overall trend in community similarity, while the rare species were shown to be more variable (Fig. 2). Over the six cycles, the common species were not found to fall below the cut-off value for within-sample variation. In contrast, however, substantial variation was observed in the detection of rare species, for which the mean change in similarity among aliquots from each sample dropped below the expected level for within-sample variation after four freeze–thaw cycles.

4. Discussion

The handling of respiratory samples for culture-independent analysis is vital if an unbiased picture of the microbial community is to be obtained. Storage of samples at −80 °C is the standard recognised method for maintenance of sample integrity during biobanking. However, whether repeated sub-sampling of these specimens, which will require repeated thawing and freezing, leads to sample degradation and changes in community composition detected has not been reported. In searching for changes in bacterial diversity due to freeze–thaw cycles, no significant overall trend was observed. A significant negative trend in community similarity was observed using the Bray–Curtis measure of similarity. Despite this observation, over the 6 cycles the change in similarity never fell below the expected level for within-sample variation, indicating that repeat freeze–thaw cycles will not affect the overall bacterial community composition. However, the rare community fell below the level of within sample variation from 4 freeze–thaw cycles. Our results challenge the long-held view that the microbial community within respiratory samples will significantly change once samples have been defrosted during subsampling. More than three freeze–thaw cycles will result in significant divergence of the rare community from the original sample. If the sample is subjected to four or more cycles community analysis may be carried out on the common community but the rare should be interpreted with care. In practical terms, these findings support the aliquoting of samples to avoid unnecessary freeze–thaw cycles.
  11 in total

Review 1.  Optimal sampling sites and methods for detection of pathogens possibly causing community-acquired lower respiratory tract infections.

Authors:  K Loens; L Van Heirstraeten; S Malhotra-Kumar; H Goossens; M Ieven
Journal:  J Clin Microbiol       Date:  2008-11-19       Impact factor: 5.948

2.  The exclusion of dead bacterial cells is essential for accurate molecular analysis of clinical samples.

Authors:  G B Rogers; P Marsh; A F Stressmann; C E Allen; T V W Daniels; M P Carroll; K D Bruce
Journal:  Clin Microbiol Infect       Date:  2010-11       Impact factor: 8.067

3.  Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis.

Authors:  G B Rogers; M P Carroll; D J Serisier; P M Hockey; G Jones; V Kehagia; G J Connett; K D Bruce
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

4.  Assessing the diagnostic importance of nonviable bacterial cells in respiratory infections.

Authors:  Geraint B Rogers; Franziska A Stressmann; Garrit Koller; Thomas Daniels; Mary P Carroll; Kenneth D Bruce
Journal:  Diagn Microbiol Infect Dis       Date:  2008-08-09       Impact factor: 2.803

5.  Use of propidium monoazide for live/dead distinction in microbial ecology.

Authors:  Andreas Nocker; Priscilla Sossa-Fernandez; Mark D Burr; Anne K Camper
Journal:  Appl Environ Microbiol       Date:  2007-06-22       Impact factor: 4.792

6.  Reducing bias in bacterial community analysis of lower respiratory infections.

Authors:  Geraint B Rogers; Leah Cuthbertson; Lucas R Hoffman; Peter A C Wing; Christopher Pope; Danny A P Hooftman; Andrew K Lilley; Anna Oliver; Mary P Carroll; Kenneth D Bruce; Christopher J van der Gast
Journal:  ISME J       Date:  2012-11-29       Impact factor: 10.302

7.  Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities.

Authors:  Christopher J van der Gast; Alan W Walker; Franziska A Stressmann; Geraint B Rogers; Paul Scott; Thomas W Daniels; Mary P Carroll; Julian Parkhill; Kenneth D Bruce
Journal:  ISME J       Date:  2010-12-09       Impact factor: 10.302

8.  Reducing the effects of PCR amplification and sequencing artifacts on 16S rRNA-based studies.

Authors:  Patrick D Schloss; Dirk Gevers; Sarah L Westcott
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

9.  Time between collection and storage significantly influences bacterial sequence composition in sputum samples from cystic fibrosis respiratory infections.

Authors:  Leah Cuthbertson; Geraint B Rogers; Alan W Walker; Anna Oliver; Tarana Hafiz; Lucas R Hoffman; Mary P Carroll; Julian Parkhill; Kenneth D Bruce; Christopher J van der Gast
Journal:  J Clin Microbiol       Date:  2014-06-11       Impact factor: 5.948

Review 10.  Molecular detection of CF lung pathogens: current status and future potential.

Authors:  Sally H Pattison; Geraint B Rogers; Martin Crockard; J Stuart Elborn; Michael M Tunney
Journal:  J Cyst Fibros       Date:  2013-02-10       Impact factor: 5.482

View more
  12 in total

Review 1.  Performing Skin Microbiome Research: A Method to the Madness.

Authors:  Heidi H Kong; Björn Andersson; Thomas Clavel; John E Common; Scott A Jackson; Nathan D Olson; Julia A Segre; Claudia Traidl-Hoffmann
Journal:  J Invest Dermatol       Date:  2017-01-04       Impact factor: 8.551

2.  Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum.

Authors:  Andrea Hahn; Amit Sanyal; Geovanny F Perez; Anamaris M Colberg-Poley; Joseph Campos; Mary C Rose; Marcos Pérez-Losada
Journal:  J Microbiol Methods       Date:  2016-09-05       Impact factor: 2.363

3.  Data Mining of Lung Microbiota in Cystic Fibrosis Patients.

Authors:  Jianguo Li; Chunyan Hao; Lili Ren; Yan Xiao; Jianwei Wang; Xuemei Qin
Journal:  PLoS One       Date:  2016-10-14       Impact factor: 3.240

Review 4.  Tiny microbes, enormous impacts: what matters in gut microbiome studies?

Authors:  Justine Debelius; Se Jin Song; Yoshiki Vazquez-Baeza; Zhenjiang Zech Xu; Antonio Gonzalez; Rob Knight
Journal:  Genome Biol       Date:  2016-10-19       Impact factor: 13.583

Review 5.  Mycobiome in the Lower Respiratory Tract - A Clinical Perspective.

Authors:  Robert Krause; Christine Moissl-Eichinger; Bettina Halwachs; Gregor Gorkiewicz; Gabriele Berg; Thomas Valentin; Jürgen Prattes; Christoph Högenauer; Ines Zollner-Schwetz
Journal:  Front Microbiol       Date:  2017-01-10       Impact factor: 5.640

6.  Commentary: Reducing Viability Bias in Analysis of Gut Microbiota in Preterm Infants at Risk of NEC and Sepsis.

Authors:  Gemma Agustí; Francesc Codony
Journal:  Front Cell Infect Microbiol       Date:  2018-06-20       Impact factor: 5.293

Review 7.  Understanding and overcoming the pitfalls and biases of next-generation sequencing (NGS) methods for use in the routine clinical microbiological diagnostic laboratory.

Authors:  Stefan A Boers; Ruud Jansen; John P Hays
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-03-05       Impact factor: 3.267

8.  The lung mycobiome: an emerging field of the human respiratory microbiome.

Authors:  Linh D N Nguyen; Eric Viscogliosi; Laurence Delhaes
Journal:  Front Microbiol       Date:  2015-02-13       Impact factor: 5.640

Review 9.  The Mycobiome in Health and Disease: Emerging Concepts, Methodologies and Challenges.

Authors:  Pei Yee Tiew; Micheál Mac Aogain; Nur A'tikah Binte Mohamed Ali; Kai Xian Thng; Karlyn Goh; Kenny J X Lau; Sanjay H Chotirmall
Journal:  Mycopathologia       Date:  2020-01-01       Impact factor: 2.574

10.  Lung function and microbiota diversity in cystic fibrosis.

Authors:  Leah Cuthbertson; Alan W Walker; Anna E Oliver; Geraint B Rogers; Damian W Rivett; Thomas H Hampton; Alix Ashare; J Stuart Elborn; Anthony De Soyza; Mary P Carroll; Lucas R Hoffman; Clare Lanyon; Samuel M Moskowitz; George A O'Toole; Julian Parkhill; Paul J Planet; Charlotte C Teneback; Michael M Tunney; Jonathan B Zuckerman; Kenneth D Bruce; Christopher J van der Gast
Journal:  Microbiome       Date:  2020-04-02       Impact factor: 14.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.